Source: Reuters BY OLIVIA ORAN AND CARL O'DONNELL Valeant Pharmaceuticals International Inc (VRX.TO) has brought in investment banks to review its options amid interest from buyout firms and other companies in a number of its businesses, according to people familiar with the matter. While Valeant has not decided to sell…...
Galderma Announces U.S. Collaboration in Aesthetics with Mentor Worldwide, LLC
Source: PR Newswire FORT WORTH, Texas, [April 4, 2016] – Galderma, a global leader in medical solutions for skin health, and Mentor Worldwide LLC, a global leader in breast aesthetics and reconstruction, today announced a new nationwide collaboration to partner with surgeons to elevate the patient experience across the companies’…...
Valeant Asks Its Lenders for Some Slack
Source: The Wall Street Journal By AUSTEN HUFFORD Updated March 30, 2016 11:45 a.m. ET Valeant Pharmaceuticals International Inc. sought some room to maneuver Wednesday, asking its lenders to relax some debt-covenant terms and give it an additional month to file its delayed annual report. The Canadian drug company said…...
Anacor Pharmaceuticals Announces Late-Breaking Oral Presentation of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that data from its Phase 3 pivotal studies of investigational drug crisaborole topical ointment, 2% will be presented at the 74th Annual Meeting of the American Academy of Dermatology in Washington, D.C. “Crisaborole Topical Ointment, 2%: a Novel, Nonsteroidal, Topical Anti-Inflammatory, Phosphodiesterase 4…...
Almirall Exercises Call Option To Acquire 100% Of Thermigen LLC
Source: BioSpace Almirall acquired a minority stake in US based company ThermiGen LLC and plans to close the complete acquisition of ThermiGen by January 31st, 2016. First step towards building a presence in the aesthetics market that helps to further consolidate its strategy in Dermatology. The potential acquisition would provide…...
Anacor Pharmaceuticals to Present Data From Long-Term Safety Study of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis at Upcoming Medical Conference
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that it will present data from the long-term safety study of crisaborole topical ointment, 2% in children and adults with mild-to-moderate atopic dermatitis at the Winter Clinical Dermatology Conference, being held in Koloa, Hawaii from January 15-20, 2016. About Crisaborole Topical Ointment, 2%…...
Valeant Names Howard Schiller as Interim CEO
Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately. Schiller, who joined Valeant as COO in 2009 after a 24-year career at…...